The outlook revision is based on a number of factors, including the completion of Gundersen’s construction project, consistent operating profitability and manageable debt burden.
Fitch also affirmed the “A+” rating on Gundersen’s $69.5 million of series 2012 bonds and $137.1 million of series 2011A bonds.
More articles on healthcare finance:
California hospital resumes services following wildfire
S&P revises Adventist Health’s outlook to stable
Kansas hospital undergoes audit after departure of CFO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
